 | • レポートコード：MRC2Q12-18275 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、局所抗真菌医薬品のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 局所抗真菌医薬品のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 局所抗真菌医薬品の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 局所抗真菌医薬品のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの局所抗真菌医薬品の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の局所抗真菌医薬品の売上および2028年までの予測に焦点を当てています。 局所抗真菌医薬品のグローバル主要企業には、Bayer、Coloplast、Sandoz、3M、Schering-Plough、Zydus Lifesciences、Teva Pharmaceuticals、Perrigo Pharmaceuticals、Roxane Laboratories、AdvaCare Pharma、Smith & Nephew Wound Care、Taro Pharmaceutical、Teligent、G & W Labs、Glenmark Pharmaceuticals、Mayne Pharma、TruPharma、Viona Pharmaceuticals、Zydus Pharmaceuticals、Acella Pharmaceuticals、Akorn、Alembic Pharmaceuticals、Bausch & Lomb Americas、Encubeなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 局所抗真菌医薬品市場は、タイプとアプリケーションによって区分されます。世界の局所抗真菌医薬品市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 パウダー、クリーム、軟膏、その他 【アプリケーション別セグメント】 病院、クリニック、薬局、家庭、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 局所抗真菌医薬品製品概要 - タイプ別市場（パウダー、クリーム、軟膏、その他） - アプリケーション別市場（病院、クリニック、薬局、家庭、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の局所抗真菌医薬品販売量予測2017-2028 - 世界の局所抗真菌医薬品売上予測2017-2028 - 局所抗真菌医薬品の地域別販売量 - 局所抗真菌医薬品の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別局所抗真菌医薬品販売量 - 主要メーカー別局所抗真菌医薬品売上 - 主要メーカー別局所抗真菌医薬品価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（パウダー、クリーム、軟膏、その他） - 局所抗真菌医薬品のタイプ別販売量 - 局所抗真菌医薬品のタイプ別売上 - 局所抗真菌医薬品のタイプ別価格 ・アプリケーション別市場規模（病院、クリニック、薬局、家庭、その他） - 局所抗真菌医薬品のアプリケーション別販売量 - 局所抗真菌医薬品のアプリケーション別売上 - 局所抗真菌医薬品のアプリケーション別価格 ・北米市場 - 北米の局所抗真菌医薬品市場規模（タイプ別、アプリケーション別） - 主要国別の局所抗真菌医薬品市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの局所抗真菌医薬品市場規模（タイプ別、アプリケーション別） - 主要国別の局所抗真菌医薬品市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の局所抗真菌医薬品市場規模（タイプ別、アプリケーション別） - 主要国別の局所抗真菌医薬品市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の局所抗真菌医薬品市場規模（タイプ別、アプリケーション別） - 主要国別の局所抗真菌医薬品市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの局所抗真菌医薬品市場規模（タイプ別、アプリケーション別） - 主要国別の局所抗真菌医薬品市場規模（トルコ、サウジアラビア） ・企業情報 Bayer、Coloplast、Sandoz、3M、Schering-Plough、Zydus Lifesciences、Teva Pharmaceuticals、Perrigo Pharmaceuticals、Roxane Laboratories、AdvaCare Pharma、Smith & Nephew Wound Care、Taro Pharmaceutical、Teligent、G & W Labs、Glenmark Pharmaceuticals、Mayne Pharma、TruPharma、Viona Pharmaceuticals、Zydus Pharmaceuticals、Acella Pharmaceuticals、Akorn、Alembic Pharmaceuticals、Bausch & Lomb Americas、Encube ・産業チェーン及び販売チャネル分析 - 局所抗真菌医薬品の産業チェーン分析 - 局所抗真菌医薬品の原材料 - 局所抗真菌医薬品の生産プロセス - 局所抗真菌医薬品の販売及びマーケティング - 局所抗真菌医薬品の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 局所抗真菌医薬品の産業動向 - 局所抗真菌医薬品のマーケットドライバー - 局所抗真菌医薬品の課題 - 局所抗真菌医薬品の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Topical Antifungals estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Topical Antifungals is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Topical Antifungals is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Topical Antifungals is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Topical Antifungals include Bayer, Coloplast, Sandoz, 3M, Schering-Plough, Zydus Lifesciences, Teva Pharmaceuticals, Perrigo Pharmaceuticals and Roxane Laboratories, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Topical Antifungals companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Topical Antifungals market. Further, it explains the major drivers and regional dynamics of the global Topical Antifungals market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Bayer
Coloplast
Sandoz
3M
Schering-Plough
Zydus Lifesciences
Teva Pharmaceuticals
Perrigo Pharmaceuticals
Roxane Laboratories
AdvaCare Pharma
Smith & Nephew Wound Care
Taro Pharmaceutical
Teligent
G & W Labs
Glenmark Pharmaceuticals
Mayne Pharma
TruPharma
Viona Pharmaceuticals
Zydus Pharmaceuticals
Acella Pharmaceuticals
Akorn
Alembic Pharmaceuticals
Bausch & Lomb Americas
Encube
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Topical Antifungals Segment by Type
Powder
Cream
Ointment
Others
Topical Antifungals Segment by Application
Hospital
Clinics
Pharmacy
Home
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Topical Antifungals market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Topical Antifungals market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Topical Antifungals, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Topical Antifungals, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Topical Antifungals revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Topical Antifungals market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Topical Antifungals revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bayer, Coloplast, Sandoz, 3M, Schering-Plough, Zydus Lifesciences, Teva Pharmaceuticals, Perrigo Pharmaceuticals and Roxane Laboratories, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Topical Antifungals in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Topical Antifungals companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Topical Antifungals revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Topical Antifungals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Powder
1.2.3 Cream
1.2.4 Ointment
1.2.5 Others
1.3 Market by Application
1.3.1 Global Topical Antifungals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Pharmacy
1.3.5 Home
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Topical Antifungals Market Perspective (2017-2028)
2.2 Topical Antifungals Growth Trends by Region
2.2.1 Topical Antifungals Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Topical Antifungals Historic Market Size by Region (2017-2022)
2.2.3 Topical Antifungals Forecasted Market Size by Region (2023-2028)
2.3 Topical Antifungals Market Dynamics
2.3.1 Topical Antifungals Industry Trends
2.3.2 Topical Antifungals Market Drivers
2.3.3 Topical Antifungals Market Challenges
2.3.4 Topical Antifungals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Topical Antifungals Players by Revenue
3.1.1 Global Top Topical Antifungals Players by Revenue (2017-2022)
3.1.2 Global Topical Antifungals Revenue Market Share by Players (2017-2022)
3.2 Global Topical Antifungals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Topical Antifungals Revenue
3.4 Global Topical Antifungals Market Concentration Ratio
3.4.1 Global Topical Antifungals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Topical Antifungals Revenue in 2021
3.5 Topical Antifungals Key Players Head office and Area Served
3.6 Key Players Topical Antifungals Product Solution and Service
3.7 Date of Enter into Topical Antifungals Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Topical Antifungals Breakdown Data by Type
4.1 Global Topical Antifungals Historic Market Size by Type (2017-2022)
4.2 Global Topical Antifungals Forecasted Market Size by Type (2023-2028)
5 Topical Antifungals Breakdown Data by Application
5.1 Global Topical Antifungals Historic Market Size by Application (2017-2022)
5.2 Global Topical Antifungals Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Topical Antifungals Market Size (2017-2028)
6.2 North America Topical Antifungals Market Size by Type
6.2.1 North America Topical Antifungals Market Size by Type (2017-2022)
6.2.2 North America Topical Antifungals Market Size by Type (2023-2028)
6.2.3 North America Topical Antifungals Market Share by Type (2017-2028)
6.3 North America Topical Antifungals Market Size by Application
6.3.1 North America Topical Antifungals Market Size by Application (2017-2022)
6.3.2 North America Topical Antifungals Market Size by Application (2023-2028)
6.3.3 North America Topical Antifungals Market Share by Application (2017-2028)
6.4 North America Topical Antifungals Market Size by Country
6.4.1 North America Topical Antifungals Market Size by Country (2017-2022)
6.4.2 North America Topical Antifungals Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Topical Antifungals Market Size (2017-2028)
7.2 Europe Topical Antifungals Market Size by Type
7.2.1 Europe Topical Antifungals Market Size by Type (2017-2022)
7.2.2 Europe Topical Antifungals Market Size by Type (2023-2028)
7.2.3 Europe Topical Antifungals Market Share by Type (2017-2028)
7.3 Europe Topical Antifungals Market Size by Application
7.3.1 Europe Topical Antifungals Market Size by Application (2017-2022)
7.3.2 Europe Topical Antifungals Market Size by Application (2023-2028)
7.3.3 Europe Topical Antifungals Market Share by Application (2017-2028)
7.4 Europe Topical Antifungals Market Size by Country
7.4.1 Europe Topical Antifungals Market Size by Country (2017-2022)
7.4.2 Europe Topical Antifungals Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Topical Antifungals Market Size (2017-2028)
8.2 Asia-Pacific Topical Antifungals Market Size by Type
8.2.1 Asia-Pacific Topical Antifungals Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Topical Antifungals Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Topical Antifungals Market Share by Type (2017-2028)
8.3 Asia-Pacific Topical Antifungals Market Size by Application
8.3.1 Asia-Pacific Topical Antifungals Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Topical Antifungals Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Topical Antifungals Market Share by Application (2017-2028)
8.4 Asia-Pacific Topical Antifungals Market Size by Region
8.4.1 Asia-Pacific Topical Antifungals Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Topical Antifungals Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Topical Antifungals Market Size (2017-2028)
9.2 Latin America Topical Antifungals Market Size by Type
9.2.1 Latin America Topical Antifungals Market Size by Type (2017-2022)
9.2.2 Latin America Topical Antifungals Market Size by Type (2023-2028)
9.2.3 Latin America Topical Antifungals Market Share by Type (2017-2028)
9.3 Latin America Topical Antifungals Market Size by Application
9.3.1 Latin America Topical Antifungals Market Size by Application (2017-2022)
9.3.2 Latin America Topical Antifungals Market Size by Application (2023-2028)
9.3.3 Latin America Topical Antifungals Market Share by Application (2017-2028)
9.4 Latin America Topical Antifungals Market Size by Country
9.4.1 Latin America Topical Antifungals Market Size by Country (2017-2022)
9.4.2 Latin America Topical Antifungals Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Topical Antifungals Market Size (2017-2028)
10.2 Middle East & Africa Topical Antifungals Market Size by Type
10.2.1 Middle East & Africa Topical Antifungals Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Topical Antifungals Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Topical Antifungals Market Share by Type (2017-2028)
10.3 Middle East & Africa Topical Antifungals Market Size by Application
10.3.1 Middle East & Africa Topical Antifungals Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Topical Antifungals Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Topical Antifungals Market Share by Application (2017-2028)
10.4 Middle East & Africa Topical Antifungals Market Size by Country
10.4.1 Middle East & Africa Topical Antifungals Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Topical Antifungals Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Topical Antifungals Introduction
11.1.4 Bayer Revenue in Topical Antifungals Business (2017-2022)
11.1.5 Bayer Recent Developments
11.2 Coloplast
11.2.1 Coloplast Company Details
11.2.2 Coloplast Business Overview
11.2.3 Coloplast Topical Antifungals Introduction
11.2.4 Coloplast Revenue in Topical Antifungals Business (2017-2022)
11.2.5 Coloplast Recent Developments
11.3 Sandoz
11.3.1 Sandoz Company Details
11.3.2 Sandoz Business Overview
11.3.3 Sandoz Topical Antifungals Introduction
11.3.4 Sandoz Revenue in Topical Antifungals Business (2017-2022)
11.3.5 Sandoz Recent Developments
11.4 3M
11.4.1 3M Company Details
11.4.2 3M Business Overview
11.4.3 3M Topical Antifungals Introduction
11.4.4 3M Revenue in Topical Antifungals Business (2017-2022)
11.4.5 3M Recent Developments
11.5 Schering-Plough
11.5.1 Schering-Plough Company Details
11.5.2 Schering-Plough Business Overview
11.5.3 Schering-Plough Topical Antifungals Introduction
11.5.4 Schering-Plough Revenue in Topical Antifungals Business (2017-2022)
11.5.5 Schering-Plough Recent Developments
11.6 Zydus Lifesciences
11.6.1 Zydus Lifesciences Company Details
11.6.2 Zydus Lifesciences Business Overview
11.6.3 Zydus Lifesciences Topical Antifungals Introduction
11.6.4 Zydus Lifesciences Revenue in Topical Antifungals Business (2017-2022)
11.6.5 Zydus Lifesciences Recent Developments
11.7 Teva Pharmaceuticals
11.7.1 Teva Pharmaceuticals Company Details
11.7.2 Teva Pharmaceuticals Business Overview
11.7.3 Teva Pharmaceuticals Topical Antifungals Introduction
11.7.4 Teva Pharmaceuticals Revenue in Topical Antifungals Business (2017-2022)
11.7.5 Teva Pharmaceuticals Recent Developments
11.8 Perrigo Pharmaceuticals
11.8.1 Perrigo Pharmaceuticals Company Details
11.8.2 Perrigo Pharmaceuticals Business Overview
11.8.3 Perrigo Pharmaceuticals Topical Antifungals Introduction
11.8.4 Perrigo Pharmaceuticals Revenue in Topical Antifungals Business (2017-2022)
11.8.5 Perrigo Pharmaceuticals Recent Developments
11.9 Roxane Laboratories
11.9.1 Roxane Laboratories Company Details
11.9.2 Roxane Laboratories Business Overview
11.9.3 Roxane Laboratories Topical Antifungals Introduction
11.9.4 Roxane Laboratories Revenue in Topical Antifungals Business (2017-2022)
11.9.5 Roxane Laboratories Recent Developments
11.10 AdvaCare Pharma
11.10.1 AdvaCare Pharma Company Details
11.10.2 AdvaCare Pharma Business Overview
11.10.3 AdvaCare Pharma Topical Antifungals Introduction
11.10.4 AdvaCare Pharma Revenue in Topical Antifungals Business (2017-2022)
11.10.5 AdvaCare Pharma Recent Developments
11.11 Smith & Nephew Wound Care
11.11.1 Smith & Nephew Wound Care Company Details
11.11.2 Smith & Nephew Wound Care Business Overview
11.11.3 Smith & Nephew Wound Care Topical Antifungals Introduction
11.11.4 Smith & Nephew Wound Care Revenue in Topical Antifungals Business (2017-2022)
11.11.5 Smith & Nephew Wound Care Recent Developments
11.12 Taro Pharmaceutical
11.12.1 Taro Pharmaceutical Company Details
11.12.2 Taro Pharmaceutical Business Overview
11.12.3 Taro Pharmaceutical Topical Antifungals Introduction
11.12.4 Taro Pharmaceutical Revenue in Topical Antifungals Business (2017-2022)
11.12.5 Taro Pharmaceutical Recent Developments
11.13 Teligent
11.13.1 Teligent Company Details
11.13.2 Teligent Business Overview
11.13.3 Teligent Topical Antifungals Introduction
11.13.4 Teligent Revenue in Topical Antifungals Business (2017-2022)
11.13.5 Teligent Recent Developments
11.14 G & W Labs
11.14.1 G & W Labs Company Details
11.14.2 G & W Labs Business Overview
11.14.3 G & W Labs Topical Antifungals Introduction
11.14.4 G & W Labs Revenue in Topical Antifungals Business (2017-2022)
11.14.5 G & W Labs Recent Developments
11.15 Glenmark Pharmaceuticals
11.15.1 Glenmark Pharmaceuticals Company Details
11.15.2 Glenmark Pharmaceuticals Business Overview
11.15.3 Glenmark Pharmaceuticals Topical Antifungals Introduction
11.15.4 Glenmark Pharmaceuticals Revenue in Topical Antifungals Business (2017-2022)
11.15.5 Glenmark Pharmaceuticals Recent Developments
11.16 Mayne Pharma
11.16.1 Mayne Pharma Company Details
11.16.2 Mayne Pharma Business Overview
11.16.3 Mayne Pharma Topical Antifungals Introduction
11.16.4 Mayne Pharma Revenue in Topical Antifungals Business (2017-2022)
11.16.5 Mayne Pharma Recent Developments
11.17 TruPharma
11.17.1 TruPharma Company Details
11.17.2 TruPharma Business Overview
11.17.3 TruPharma Topical Antifungals Introduction
11.17.4 TruPharma Revenue in Topical Antifungals Business (2017-2022)
11.17.5 TruPharma Recent Developments
11.18 Viona Pharmaceuticals
11.18.1 Viona Pharmaceuticals Company Details
11.18.2 Viona Pharmaceuticals Business Overview
11.18.3 Viona Pharmaceuticals Topical Antifungals Introduction
11.18.4 Viona Pharmaceuticals Revenue in Topical Antifungals Business (2017-2022)
11.18.5 Viona Pharmaceuticals Recent Developments
11.19 Zydus Pharmaceuticals
11.19.1 Zydus Pharmaceuticals Company Details
11.19.2 Zydus Pharmaceuticals Business Overview
11.19.3 Zydus Pharmaceuticals Topical Antifungals Introduction
11.19.4 Zydus Pharmaceuticals Revenue in Topical Antifungals Business (2017-2022)
11.19.5 Zydus Pharmaceuticals Recent Developments
11.20 Acella Pharmaceuticals
11.20.1 Acella Pharmaceuticals Company Details
11.20.2 Acella Pharmaceuticals Business Overview
11.20.3 Acella Pharmaceuticals Topical Antifungals Introduction
11.20.4 Acella Pharmaceuticals Revenue in Topical Antifungals Business (2017-2022)
11.20.5 Acella Pharmaceuticals Recent Developments
11.21 Akorn
11.21.1 Akorn Company Details
11.21.2 Akorn Business Overview
11.21.3 Akorn Topical Antifungals Introduction
11.21.4 Akorn Revenue in Topical Antifungals Business (2017-2022)
11.21.5 Akorn Recent Developments
11.22 Alembic Pharmaceuticals
11.22.1 Alembic Pharmaceuticals Company Details
11.22.2 Alembic Pharmaceuticals Business Overview
11.22.3 Alembic Pharmaceuticals Topical Antifungals Introduction
11.22.4 Alembic Pharmaceuticals Revenue in Topical Antifungals Business (2017-2022)
11.22.5 Alembic Pharmaceuticals Recent Developments
11.23 Bausch & Lomb Americas
11.23.1 Bausch & Lomb Americas Company Details
11.23.2 Bausch & Lomb Americas Business Overview
11.23.3 Bausch & Lomb Americas Topical Antifungals Introduction
11.23.4 Bausch & Lomb Americas Revenue in Topical Antifungals Business (2017-2022)
11.23.5 Bausch & Lomb Americas Recent Developments
11.24 Encube
11.24.1 Encube Company Details
11.24.2 Encube Business Overview
11.24.3 Encube Topical Antifungals Introduction
11.24.4 Encube Revenue in Topical Antifungals Business (2017-2022)
11.24.5 Encube Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer